The PCT Databank presents historical data as reported to WHO. This tool is designed to empower users to leverage their familiarity with Excel and the simplicity of the Global Health Observatory (GHO) to rapidly construct summaries that can be shared as they are viewed.
Article on the importance of cross-border issues in onchocerciasis elimination programmes. Bush, Sodahlon, Downs and Mackenzie, International Health, Volume 10, Issue suppl_1, 1 March 2018, Pages i54–i59.
Article on the use of alternative (or complementary) treatment strategies (ATSs) to accelerate the elimination of onchocerciasis. Boussinesq et al., International Health, Volume 10, Issue suppl_1, 1 March 2018, Pages i40–i48.
A review summarizing the progress made in identifying diagnostics that meet the specialized requirements needed to verify onchocerciasis elimination, as well as a discussion of why these tests were selected and a summary of the needs that still exist to complete the arsenal of diagnostic tools that will be useful as the goal of elimination is achieved.
This publication reviews the history of the efforts to control onchocerciasis in Yemen and the current status of the disease, and identifies the essential changes needed to a mass drug administration (MDA) approach as the national program addresses elimination.
Journal article discussing the concept that all areas where the worm that causes onchocerciasis might currently be transmitted—and where mass drug administration (MDA) with ivermectin treatment has not been delivered previously—must now be identified by careful, detailed “elimination mapping”.
The purpose of this publication is to provide proof of concept that, through a strong partnership between Merck’s donation of Mectizan, the endemic countries and donors, we can eliminate onchocerciasis, a scourge that was once classified as a disease that could only be controlled.
This article addresses elimination of onchocerciasis transmission in the Americas. With four of the six originally endemic American countries now WHO verified as having eliminated onchocerciasis transmission, and 95% of ivermectin treatments in the region halted, the regional focus is now on the remaining active transmission zone, called the Yanomami Area, on the border between Venezuela and Brazil.